PUBLISHER: TechNavio | PRODUCT CODE: 2109651
PUBLISHER: TechNavio | PRODUCT CODE: 2109651
Global Bioactive Glass Market 2026-2030
The global bioactive glass market is forecasted to grow by USD 2085.0 mn during 2025-2030, accelerating at a CAGR of 20.8% during the forecast period. The report on the global bioactive glass market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing geriatric population base accelerates global demand bone graft substitutes, rising clinical preference dental care remineralization boosts specialized material consumables, technological advancements nanotechnology integration enhance biological performance tissue engineering scaffolds.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 19.6% |
| CAGR | 20.8% |
| Incremental Value | $2085.0 mn |
Technavio's global bioactive glass market is segmented as below:
By Product
- Silicate-based glass
- Phosphate-based glass
- Borate-based glass
By Application
- Medical
- Dentistry
- Cosmetics
- Others
By Form Factor
- Powders and nano-powders
- Granules
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the extensive incorporation mesoporous bioactive glass matrices optimizes targeted localized drug delivery as one of the prime reasons driving the global bioactive glass market growth during the next few years. Also, growing utilization additive manufacturing architectures enables personalized patient specific orthopedic scaffolds and rapid penetration antimicrobial ion enriched coatings enhances medical device osseointegration performance will lead to sizable demand in the market.
The report on the global bioactive glass market covers the following areas:
- Global bioactive glass market sizing
- Global bioactive glass market forecast
- Global bioactive glass market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global bioactive glass market vendors that include Arthrex Inc., Baxter International Inc., Berkeley Advanced Biomaterials, Biocomposites Ltd., BioMin Technologies Ltd., BISCO Inc., Bonalive Biomaterials Ltd., BoneSupport Holding AB, CAM Bioceramics BV, Ed. Geistlich Sohne AG, GC Corp., GNI Group Ltd., Medtronic Plc, Mo Sci Corp., NORAKER, NovaBone Products LLC, SCHOTT AG, Stryker Corp., Synthera Lifesciences Pvt. Ltd., Zimmer Biomet Holdings Inc.. Also, the global bioactive glass market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by Form Factor
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Bioactive Glass Market 2020 - 2024
- Historic Market Size - Data Table on Global Bioactive Glass Market 2020 - 2024 ($ million)
- 5.2 Product segment analysis 2020 - 2024
- Historic Market Size - Product Segment 2020 - 2024 ($ million)
- 5.3 Application segment analysis 2020 - 2024
- Historic Market Size - Application Segment 2020 - 2024 ($ million)
- 5.4 Form Factor segment analysis 2020 - 2024
- Historic Market Size - Form Factor Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on global bioactive glass market
- 6.2 Impact of geopolitical conflicts on global bioactive glass market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Product
- 8.1 Market segments
- 8.2 Comparison by Product
- 8.3 Silicate-based glass - Market size and forecast 2025-2030
- 8.4 Phosphate-based glass - Market size and forecast 2025-2030
- 8.5 Borate-based glass - Market size and forecast 2025-2030
- 8.6 Market opportunity by Product
- Market opportunity by Product ($ million)
9 Market Segmentation by Application
- 9.1 Market segments
- 9.2 Comparison by Application
- 9.3 Medical - Market size and forecast 2025-2030
- 9.4 Dentistry - Market size and forecast 2025-2030
- 9.5 Cosmetics - Market size and forecast 2025-2030
- 9.6 Others - Market size and forecast 2025-2030
- 9.7 Market opportunity by Application
- Market opportunity by Application ($ million)
10 Market Segmentation by Form Factor
- 10.1 Market segments
- 10.2 Comparison by Form Factor
- 10.3 Powders and nano-powders - Market size and forecast 2025-2030
- 10.4 Granules - Market size and forecast 2025-2030
- 10.5 Market opportunity by Form Factor
- Market opportunity by Form Factor ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 Japan - Market size and forecast 2025-2030
- 12.5.3 India - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Indonesia - Market size and forecast 2025-2030
- 12.5.6 Thailand - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.3 UAE - Market size and forecast 2025-2030
- 12.6.4 Turkey - Market size and forecast 2025-2030
- 12.6.5 Argentina - Market size and forecast 2025-2030
- 12.6.6 Colombia - Market size and forecast 2025-2030
- 12.6.7 South Africa - Market size and forecast 2025-2030
- 12.6.8 Israel - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Increasing geriatric population base accelerates global demand bone graft substitutes
- Rising clinical preference dental care remineralization boosts specialized material consumables
- Technological advancements nanotechnology integration enhance biological performance tissue engineering scaffolds
- 13.2 Market challenges
- High manufacturing expenditure limits general commercial viability across emerging healthcare markets
- Prolonged regulatory evaluation pathways delay rapid introduction innovative bioactive material formulations
- Inadequate structural mechanical strength restricts broader clinical deployment load bearing applications
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Extensive incorporation mesoporous bioactive glass matrices optimizes targeted localized drug delivery
- Growing utilization additive manufacturing architectures enables personalized patient specific orthopedic scaffolds
- Rapid penetration antimicrobial ion enriched coatings enhances medical device osseointegration performance
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Arthrex Inc.
- Arthrex Inc. - Overview
- Arthrex Inc. - Product / Service
- Arthrex Inc. - Key offerings
- SWOT
- 15.5 Baxter International Inc.
- Baxter International Inc. - Overview
- Baxter International Inc. - Business segments
- Baxter International Inc. - Key offerings
- Baxter International Inc. - Segment focus
- SWOT
- 15.6 Berkeley Advanced Biomaterials
- Berkeley Advanced Biomaterials - Overview
- Berkeley Advanced Biomaterials - Product / Service
- Berkeley Advanced Biomaterials - Key offerings
- SWOT
- 15.7 Biocomposites Ltd.
- Biocomposites Ltd. - Overview
- Biocomposites Ltd. - Product / Service
- Biocomposites Ltd. - Key offerings
- SWOT
- 15.8 BioMin Technologies Ltd.
- BioMin Technologies Ltd. - Overview
- BioMin Technologies Ltd. - Product / Service
- BioMin Technologies Ltd. - Key offerings
- SWOT
- 15.9 BISCO Inc.
- BISCO Inc. - Overview
- BISCO Inc. - Product / Service
- BISCO Inc. - Key offerings
- SWOT
- 15.10 Bonalive Biomaterials Ltd.
- Bonalive Biomaterials Ltd. - Overview
- Bonalive Biomaterials Ltd. - Product / Service
- Bonalive Biomaterials Ltd. - Key offerings
- SWOT
- 15.11 Ed. Geistlich Sohne AG
- Ed. Geistlich Sohne AG - Overview
- Ed. Geistlich Sohne AG - Product / Service
- Ed. Geistlich Sohne AG - Key offerings
- SWOT
- 15.12 GC Corp.
- GC Corp. - Overview
- GC Corp. - Product / Service
- GC Corp. - Key offerings
- SWOT
- 15.13 GNI Group Ltd.
- GNI Group Ltd. - Overview
- GNI Group Ltd. - Product / Service
- GNI Group Ltd. - Key offerings
- SWOT
- 15.14 Medtronic Plc
- Medtronic Plc - Overview
- Medtronic Plc - Business segments
- Medtronic Plc - Key news
- Medtronic Plc - Key offerings
- Medtronic Plc - Segment focus
- SWOT
- 15.15 SCHOTT AG
- SCHOTT AG - Overview
- SCHOTT AG - Product / Service
- SCHOTT AG - Key offerings
- SWOT
- 15.16 Stryker Corp.
- Stryker Corp. - Overview
- Stryker Corp. - Business segments
- Stryker Corp. - Key offerings
- Stryker Corp. - Segment focus
- SWOT
- 15.17 Synthera Lifesciences Pvt. Ltd.
- Synthera Lifesciences Pvt. Ltd. - Overview
- Synthera Lifesciences Pvt. Ltd. - Product / Service
- Synthera Lifesciences Pvt. Ltd. - Key offerings
- SWOT
- 15.18 Zimmer Biomet Holdings Inc.
- Zimmer Biomet Holdings Inc. - Overview
- Zimmer Biomet Holdings Inc. - Business segments
- Zimmer Biomet Holdings Inc. - Key news
- Zimmer Biomet Holdings Inc. - Key offerings
- Zimmer Biomet Holdings Inc. - Segment focus
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
